medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2005, Number 3

<< Back Next >>

Rev Esp Med Quir 2005; 10 (3)

Cateterismo cardiaco de corta estancia

Menchi XRA, Flores FJ, Zaragoza RG, Arrieta MEM, Sánchez HO, Blanco CM, Sánchez PJL, Jiménez VA

Language: Spanish
References: 10
Page: 35-38
PDF size: 188.99 Kb.


ABSTRACT

Efficacy of the hemostatic puncture closure 8 fr Angio Seal device for percutaneous puncture closure after a catheterize has been previously demonstrated, but the experience provided has been obtained with 8 fr device. Objective. Evaluate the efficacy and safe of the hemostatic 6 fr Angio Seal device for early deambulation post-diagnostic and/or therapeutic catheterization is established. Patients and methods. Prospective study of 20 consecutive patients no randomized either for application of the 6 fr Angio Seal device (group A; n=10), in which early ambulation was indicated, or manual compression (group B; n=10), with ambulation 8 hr after cardiac catheterization. Basal data, including clinical and angiographic characteristics and previous treatment with heparina and platelet aggregation inhibitor were similar in both groups. Results. time of hemostasia was significantly shorter in group A than in group B (4.0 ± 3.9 min in A vs 19 +- 7.8 min in B; P‹0.001), and with early ambulation (4.3±0.5 hr in A vs 8.3±0.3 hr in B; P‹0.001) no local complications were observed. Conclusions. The 6 fr Angio Seal hemostatic device diminished the hemostasia time and early ambulation could be achieved. In this study no complications due to early movilization were observed.


REFERENCES

  1. Wyman RM, Safian RD, Portway V, Skillman JJ, McKay RG, Baim DS. Current complication of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1998;12:1400-06

  2. André ML, Argibay V, Guillem P, Vázquez A, Gómez M: Deambulación precoz con dispositivo Angio Seal tras angioplastia coronaria. Comparación frente a compresión mecánica. J Am Coll Cardiol 1999;11:1345-51

  3. Marco J, Fajadet J, Farah B, Laborde JC et al: The Paris Course on Revascularization. May 2004, 472-85

  4. Johnson LW, Lozner EC, Krone R, Cambell A, Chiang YC. Coronary arteriography 1994-87: a report of the Society for Cardiac Angiography and Interventions: results and complication. Cathe Cardiovasc Diagn 1989;17:5-10

  5. Marso SP, Grffin BP, Topol EJ: Cardiología, The Cleveland clinic foundation. Ed Marban 2002;700-21

  6. Sprouse LR, Botta DM, Hamilton IN: The management of peripheral complication associated with the use of percutaneus suture-mediated closure. J Vasc Surg 2001;33(4):688-93

  7. Wetter DR, Rickli H, Von Smekal A, Amann FW: Early sheat renoval after coronary interventions with use of a sutureediated closure device: clinical outcome abd results of Doppler US evaluation. J Vasc Interv Radiol 2001;11(8):1033-37

  8. Kussmaul WG, Buchbinder M, Whitlow PL, Aker UT. Rapid arterial hemostasis and decreased access site complications after catheterization and angioplasty: Results of a ramdomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685-92

  9. Silver S. Hemostasis success rates and local complications with collagen alter femoral access for cardiac catheterization: Analysis of 6007 published patient. Am Heart J 1998;135:152-56

  10. Ward SR, Casale P. Raymond R, Kussmaul WG. Efficacy and safety of a hemostatic puncture closure device with




2020     |     www.medigraphic.com